AxoGen Inc (AXGN): Market Cap to Revenue

Symbol and logo of brand AxoGen Inc (AXGN)

The market capitalization-to-revenue ratio reflects the market valuation of AxoGen, Inc. (AXGN), where the parameter reaches 12.40. AxoGen, Inc. (AXGN) operates a high-tech sterile processing center for biomaterials in Ohio. Growth is driven by the popularity of Avance grafts and a commitment to a profitable cash flow. Seamless deliveries to clinics are guaranteed through automated warehouses and strict adherence to temperature-controlled transportation.

AXGN AxoGen Inc P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Axogen Corp (AXGN)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:AXGN axogeninc.com
Core merchandise of AxoGen, Inc.

The P/S ratio reflects the market value of a business relative to its annual revenue, allowing for an assessment of an asset's overvaluation through the relationship between market capitalization and operating income. By analyzing the P/S ratio dynamics of AxoGen, Inc. (AXGN), an investor can identify an unjustified gap between the price and actual sales of AxoGen, Inc. (AXGN), which is critical given the high costs of clinical validation and the slow adoption of innovations by surgeons.

Competitors of AxoGen, Inc.

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales si-bone.com SIBN|Price-to-Revenue Ratio Orthofix (OFIX)|Bioventus Inc (BVS) - Price-to-Revenue Multiple|OrthoPediatrics - Market Cap to Revenue|P/S Multiple Treace Corp TMCI|Strata Critical Medical Inc - P/S Multiple|Price-to-Revenue Coefficient carlsmed.com CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|XTNT: P/S Multiple|n1mtc.com (NMTC) - P/S Multiple|Market Cap to Revenue MODD|Market Cap to Revenue Ratio MYO (Myomo Inc.)|Price-to-Revenue Ratio Envoy Medical, Inc (COCH)|VVOS - Price to Sales|P/S Multiple NVNO (enVVeno Medical)|Price-to-Revenue Multiple Sintx Technologies Inc|Tenon Medical - P/S Multiple|Price to Sales ReWalk Robotics|autonomix.com (AMIX) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio IVF|Market Cap to Revenue BBLG|AXNX: Market Capitalization-to-Revenue Ratio|P/S Multiple BIOL|Price-to-Revenue Coefficient dynatronics.com|Price-to-Revenue Ratio Paragon 28 FNA|INVO: Market Cap to Revenue Ratio